Home > Name List By a > Aliskiren

CAS No 173334-57-1 , Aliskiren

Search by region :

Select to

173334-57-1 Aliskiren

Contact Supplier

173334-57-1 Aliskiren

  • China DRAGONFARM CO., LTD [Manufacturers]
  • Tel: +86-571-85899500/85899501
  • Fax: +86-571-85899502
  • Address: 1001-1002,Huahong Mansion, No.1 Building 238 Tianmushan Road,Hangzhou,China Hangzhou,zhejiangChina
Contact Supplier

173334-57-1 Aliskiren

  • China hexo chemical [Manufacturers]
  • Tel: 0571-56638036  0571-56638015
  • Address: Hangzhou null,nullChina
Contact Supplier

173334-57-1 Aliskiren

  • China KWWTL?Biotechnology?Co.,Ltd. [Manufacturers]
  • Tel: +86-20-83836486
  • Fax: +86-20-83837489
  • Address: Room 1005, Daxin Building, No.538 North DeZheng Road, Guangzhou China, 510045 GUANGZHOU,GUANGDONGChina
Contact Supplier

173334-57-1 Aliskiren [173334-57-1]

  • China KINFON PHARMA AND CHEMICAL CO.,LTD [Manufacturer, Trading Company]
  • Tel: 86-23-86390204
  • Fax: 86-23-86390204
  • Address: Hua Long Road 219#; Jiu Long Industrial Park CHONGQ null,ChongqChina
Contact Supplier

173334-57-1 Aliskiren

  • China Xingcheng Chempharm Co.,Ltd. [Manufacturers]
  • Tel: +86-576-88551200
  • Fax: +86-576-88225056
  • Address: Area B ,10F,289#,Shifu Road,Taizhou,zhejiang Taizhou,ZhejiangChina
Contact Supplier

Select to

References of Aliskiren
Title: Aliskiren
CAS Registry Number: 173334-57-1
CAS Name: (aS,gS,dS,zS)-d-Amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-g-hydroxy-4-methoxy-3-(3-methoxypropoxy)-a,z-bis(1-methylethyl)benzeneoctanamide
Synonyms: (2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2-methylpropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide; 5S-amino-4S-hydroxy-2S,7S-diisopropyl-8-[4-methoxy-3-(3-methoxypropyloxy)phenyl]octanoic acid N-(2-carbamoyl-2,2-dimethylethyl)amide
Manufacturers' Codes: CGP-60536
Molecular Formula: C30H53N3O6
Molecular Weight: 551.76
Percent Composition: C 65.30%, H 9.68%, N 7.62%, O 17.40%
Literature References: Orally active, synthetic nonpeptide renin inhibitor. Prepn: R. G?schke et al., EP 678503; eidem, US 5559111 (1995, 1996 both to Ciba-Geigy); H, Rüeger et al., Tetrahedron Lett. 41, 10085 (2000). Synthesis: A. Dondoni et al., ibid. 42, 4819 (2001). Determn by HPLC in biological fluids: G. Lefevre, S. Gauron, J. Chromatogr. B 738, 129 (2000); by RIA in plasma: G. Lefevre et al., J. Immunoassay 21, 65 (2000). Structure activity study: J. M. Wood et al., Biochem. Biophys. Res. Commun. 308, 698 (2003). Clinical pharmacology: J. Nussberger et al., Hypertension 39, e1 (2002). Clinical study: A. H. Gradman et al., Circulation 111, 1012 (2005). Review of development and therpaeutic potential: K. Allikmets, Curr. Opin. Invest. Drugs 3, 1479-1482 (2002).
Properties: pKa 9.49. Log P (octanol/water): 2.45 (pH 7.4). Soly in water: >350 mg/ml (pH 7.4).
pKa: pKa 9.49
Log P: Log P (octanol/water): 2.45 (pH 7.4)
 
Derivative Type: Hemifumarate
CAS Registry Number: 173334-58-2
Manufacturers' Codes: CGP-60536B; SPP-100
Trademarks: Rasilez (Novartis)
Molecular Formula: 2C30H53N3O6.C4H4O4
Molecular Weight: 1219.59
Percent Composition: C 63.03%, H 9.09%, N 6.89%, O 20.99%
 
Therap-Cat: Antihypertensive.
Keywords: Antihypertensive; Renin Inhibitor.